China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
India has a pivotal role in eliminating TB
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
Subscribe To Our Newsletter & Stay Updated
